Hormonal therapy in cancer of the breast.XX. Effect of testololactone or testosterone propionate on clinical course and hormonal excretion
- 1 May 1962
- Vol. 15 (3) , 636-640
- https://doi.org/10.1002/1097-0142(196205/06)15:3<636::aid-cncr2820150328>3.0.co;2-9
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Hormonal therapy in cancer of the breast.XIX. Effect of oral administration of Δ1-testololactone on clinical course and hormonal excretionCancer, 1962
- Hormonal therapy in cancer of the breast.XVI. The effect of Δ1-testololactone on clinical course and hormonal excretionCancer, 1960
- The Singularly Brief Anabolic Activity of Testololactone, A Compound Lacking AndrogenicityExperimental Biology and Medicine, 1951
- Hormonal therapy in cancer of the breast.I. The effect of testosterone propionate therapy on clinical course and hormonal excretionCancer, 1951